Treat Opica:Oncci 16:9 2015 9 EFTA00810560 VERU-111: novel, oral, next generation, tubulin inhibitor targeting a and p subunits of microtubuies Precllnical Product profilel-3 • low nanomolar inhibition of tubulin polymerization • High oral bioovailability • High brain penetration • Not a substrate for